Cargando…
Preoperative blood testing for glioblastoma, brain metastases, and primary central nervous system lymphoma differentiation
BACKGROUND: Differentiating glioblastoma (GBM), brain metastases, and primary central nervous system lymphoma (PCNSL) in clinical practice is difficult. This study aimed to evaluate the diagnostic value of routine blood biomarkers in patients with GBM, brain metastases, and PCNSL and find a preopera...
Autores principales: | Wang, Song-Quan, Yuan, Qing, Zhang, Guang-Tao, Qian, Hai-Peng, Liu, Zhi-Dan, Wang, Jia-Wei, Cai, Hong-Qing, Wan, Jing-Hai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841480/ https://www.ncbi.nlm.nih.gov/pubmed/35261885 http://dx.doi.org/10.21037/tcr-21-1957 |
Ejemplares similares
-
Extraneural Metastases of Glioblastoma without Simultaneous Central Nervous System Recurrence
por: Kim, Wonki, et al.
Publicado: (2014) -
Near Misdiagnosis of Glioblastoma as Primary Central Nervous System Lymphoma
por: Bhatt, Vijaya Raj, et al.
Publicado: (2014) -
A Deep Learning Model for Preoperative Differentiation of Glioblastoma, Brain Metastasis and Primary Central Nervous System Lymphoma: A Pilot Study
por: Tariciotti, Leonardo, et al.
Publicado: (2022) -
Curative effect of methotrexate combined with teniposide in the treatment of primary central nervous system lymphoma
por: Wang, Yi-Xia, et al.
Publicado: (2020) -
Identifying Differential Expression Genes and Prognostic Signature Based on Subventricular Zone Involved Glioblastoma
por: Yuan, Qing, et al.
Publicado: (2022)